Overview
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
Indication
与依维莫司联合，用于既往接受过酪氨酸激酶抑制剂治疗失败的晚期肾细胞癌患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/07/02 | Not Applicable | Active, not recruiting | Dong Wen | ||
2024/12/11 | Phase 2 | Recruiting | Li-kun Chen | ||
2024/11/12 | Phase 3 | Recruiting | |||
2024/10/31 | Phase 3 | Active, not recruiting | |||
2024/08/29 | Phase 1 | Not yet recruiting | |||
2024/07/26 | Phase 2 | Not yet recruiting | Hao Zeng | ||
2023/10/25 | Phase 2 | Completed | |||
2022/05/20 | Phase 2 | Completed | |||
2022/05/19 | Phase 2 | Completed | |||
2021/02/10 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Vorolanib Tablets | 国药准字H20230013 | 化学药品 | 片剂 | 6/7/2023 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.